Optimization of Experimental Conditions for In vitro P-glycoprotein Assay Using LLC-GA5 Cells |
Ahn, A-Ra
(Division of Biopharmaceutics, College of Pharmacy, Kyung Hee University)
Oh, Ju-Hee (Division of Biopharmaceutics, College of Pharmacy, Kyung Hee University) Lee, Joo-Hyun (Division of Biopharmaceutics, College of Pharmacy, Kyung Hee University) Lee, Young-Joo (Division of Biopharmaceutics, College of Pharmacy, Kyung Hee University) |
1 | Shapiro A.B., Ling V., 1994. ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J. Biol. Chem. 269, 3745-3754. |
2 | Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A., Borst P., 1995. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96, 1698-1705. DOI |
3 | Takada T., Suzuki H., Gotoh Y., Sugiyama Y., 2005. Regulation of the cell surface expression of human BCRP/ABCG2 by the phosphorylation state of Akt in polarized cells. Drug Metab. Dispos. 33, 905-909. DOI |
4 | Tanigawara Y., Okamura N., Hirai M., Yasuhara M., Ueda K., Kioka N., Komano T., Hori R., 1992. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J. Pharmacol. Exp. Ther. 263, 840-845. |
5 | Ueda K., Okamura N., Hirai M., Tanigawara Y., Saeki T., Kioka N., Komano T., Hori R., 1992. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J. Biol. Chem. 267, 24248-24252. |
6 | Vollrath V., Wielandt A.M., Acuna C., Duarte I., Andrade L., Chianale J., 1994. Effect of colchicine and heat shock on multidrug resistance gene and P-glycoprotein expression in rat liver. J. Hepatol. 21, 754-763. DOI |
7 | Yokota A., Kimura S., Masuda S., Ashihara E., Kuroda J., Sato K., Kamitsuji Y., Kawata E., Deguchi Y., Urasaki Y., Terui Y., Ruthardt M., Ueda T., Hatake K., Inui K., Maekawa T., 2007. INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity. Blood 109, 306-314. DOI |
8 | Foster R.F., Thompson J.M., Kaufman S.J., 1987. A laminin substrate promotes myogenesis in rat skeletal muscle cultures: analysis of replication and development using antidesmin and anti-BrdUrd monoclonal antibodies. Dev. Biol. 122, 11-20. DOI |
9 | Al-Shawi M.K., Omote H., 2005. The remarkable transport mechanism of P-glycoprotein: a multidrug transporter. J. Bioenerg. Biomembr. 37, 489-496. DOI |
10 | Balimane P.V., Han Y.H., Chong S., 2006. Current industrial practices of assessing permeability and P-glycoprotein interaction. AAPS J. 8, E1-13. DOI |
11 | Gatlik-Landwojtowicz E., Aanismaa P., Seelig A., 2004. The rate of P-glycoprotein activation depends on the metabolic state of the cell. Biochemistry 43, 14840-14851. DOI |
12 | Lown K.S., Mayo R.R., Leichtman A.B., Hsiao H.L., Turgeon D.K., Schmiedlin-Ren P., Brown M.B., Guo W., Rossi S.J., Benet L.Z., Watkins P.B., 1997. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavail-ability of cyclosporine. Clin. Pharmacol. Ther. 62, 248-260. DOI |
13 | Sarkadi B., Homolya L., Szakacs G. Varadi A., 2006. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol. Rev. 86, 1179-1236. DOI |